Kohjin Bio Future Growth
Future criteria checks 3/6
Kohjin Bio is forecast to grow earnings and revenue by 25.7% and 3.7% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 12% in 3 years.
Key information
25.7%
Earnings growth rate
17.8%
EPS growth rate
| Biotechs earnings growth | 9.2% |
| Revenue growth rate | 3.7% |
| Future return on equity | 12.0% |
| Analyst coverage | Low |
| Last updated | 28 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 5,130 | 671 | -189 | 980 | 1 |
| 3/31/2025 | 4,717 | 618 | -254 | 482 | 1 |
| 3/31/2024 | 4,770 | 384 | 261 | 823 | N/A |
| 3/31/2023 | 4,742 | 829 | N/A | N/A | N/A |
| 3/31/2022 | 3,947 | 587 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 177A's forecast earnings growth (25.7% per year) is above the savings rate (0.3%).
Earnings vs Market: 177A's earnings (25.7% per year) are forecast to grow faster than the JP market (7.9% per year).
High Growth Earnings: 177A's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 177A's revenue (3.7% per year) is forecast to grow slower than the JP market (4.1% per year).
High Growth Revenue: 177A's revenue (3.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 177A's Return on Equity is forecast to be low in 3 years time (12%).